What is NDC 67877-608?

67877-608 is the product NDC for Dapagliflozin, Dapagliflozin 5 mg/1 tablet, film coated, listed with the FDA by Ascend Laboratories, LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.

Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Dapagliflozin?

46 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Dapagliflozin NDC 67877-608 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)67877-608Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67877-0608Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
67877-608-05	6787706080567877060805	500 TABLET, FILM COATED in 1 BOTTLE (67877-608-05)Marketed from Apr 6, 2026
67877-608-30	6787706083067877060830	30 TABLET, FILM COATED in 1 BOTTLE (67877-608-30)Marketed from Apr 6, 2026
67877-608-33	6787706083367877060833	1 BLISTER PACK in 1 CARTON (67877-608-33) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Apr 6, 2026
67877-608-90	6787706089067877060890	90 TABLET, FILM COATED in 1 BOTTLE (67877-608-90)Marketed from Apr 6, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dapagliflozin
Generic name (nonproprietary): dapagliflozin
Active ingredients: Dapagliflozin — 5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Ascend Laboratories, LLCNDC labeler code 67877
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211545
Marketing start: Apr 6, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Sodium-Glucose Transporter 2 Inhibitors (Mechanism)
Identifiers: Product ID 67877-608_64617eef-d520-422b-aa99-d259b60c865fSPL ID 64617eef-d520-422b-aa99-d259b60c865f
Pharmacologic class: Sodium-Glucose Cotransporter 2 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N467877060805 followed by a unit qualifier and the quantity

Package 67877-0608-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 67877-608

What is NDC 67877-608?: 67877-608 is the product NDC for Dapagliflozin, Dapagliflozin 5 mg/1 tablet, film coated, listed with the FDA by Ascend Laboratories, LLC. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Dapagliflozin.
What is the active ingredient?: Dapagliflozin.
Who is the labeler?: Ascend Laboratories, LLC, NDC labeler code 67877. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Dapagliflozin?: 46 other product NDCs are listed under this name. See all Dapagliflozin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Dapagliflozin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Dapagliflozin	Dapagliflozin 5 mg/1	TabletOral	Micro Labs Limited	42571-317	42571-0317-1042571-0317-3042571-0317-90
Dapagliflozin	Dapagliflozin 10 mg/1	TabletOral	Micro Labs Limited	42571-318	42571-0318-1042571-0318-3042571-0318-90
Dapagliflozin	Dapagliflozin 5 mg/1	Tablet, Film coatedOral	AvKARE	73190-072	73190-0072-3073190-0072-90
Dapagliflozin	Dapagliflozin 10 mg/1	Tablet, Film coatedOral	AvKARE	73190-073	73190-0073-3073190-0073-90
Dapagliflozin	Dapagliflozin 5 mg/1	Tablet, Film coatedOral	ANI Pharmaceuticals, Inc.	70954-856	70954-0856-10
Dapagliflozin	Dapagliflozin 10 mg/1	Tablet, Film coatedOral	ANI Pharmaceuticals, Inc.	70954-857	70954-0857-10
Dapagliflozin	Dapagliflozin 2,3-butanediol monohydrate 5 mg/1	Tablet, Film coatedOral	Biocon Pharma Inc.	70377-023	70377-0023-1170377-0023-12
Dapagliflozin	Dapagliflozin 2,3-butanediol monohydrate 10 mg/1	Tablet, Film coatedOral	Biocon Pharma Inc.	70377-024	70377-0024-1170377-0024-12
Dapagliflozin	Dapagliflozin 5 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals, Inc.	0480-3527	00480-3527-0500480-3527-5600480-3527-98
Dapagliflozin	Dapagliflozin 10 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals, Inc.	0480-3528	00480-3528-0500480-3528-5600480-3528-98

All 47 Dapagliflozin NDCs

Other NDCs under ANDA 211545

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211545
Product	Strength	Form · route	Labeler	Product NDC
Dapagliflozin	Dapagliflozin 10 mg/1	Tablet, Film coatedOral	Ascend Laboratories, LLC	67877-609